Deuterium Reagents for Pharmaceutical Advancement
We’re excited to partner with Ascensus Specialties and Speciality Chemicals Magazine for an upcoming webinar exploring how deuteration is transforming pharmaceutical development.
The session will feature insights from Karl Matos, Ph.D., Technical Director at Ascensus Specialties, and Katherine Burns, Ph.D., Life Sciences Sales Manager at Camida, who will explore the role of deuterium reagents in advancing pharmaceutical innovation.
Deuteration is transforming the way researchers approach pharmaceutical development. By strategically incorporating deuterium, drug candidates can demonstrate improved stability, extended half-life, and optimized performance.
This webinar explores how advanced deuteration reagents are driving innovation in drug discovery and development.
What You’ll Learn:
- The science behind deuteration and its impact on pharmaceutical R&D
- How specialized reagents enable precise, selective incorporation of deuterium
- Practical applications in enhancing drug metabolism, safety, and efficacy
- Real-world examples of how deuteration supports next-generation therapies
This webinar is designed for pharmaceutical researchers, process chemists, R&D scientists and anyone in drug development who wants to explore the potential of deuterium chemistry.
Date: Wednesday 1st October, 2025 – 2:00pm
